The purpose of HTA is to provide high-quality information to decision makers about the clinical effectiveness, cost-effectiveness, and broader impact of drugs, medical technologies, and health systems.
EuropaBio is a founding member of the EPAA – the European Platform for Alternative Approaches to
Health Technology Assessment (or HTA) is the ‘multi-disciplinary field of policy analysis, which
Biological medicines are far more complex and usually much bigger than chemical medicines, which
There is no common European consensus on how to reward healthcare innovation.
Manufacturing biological medicines is generally more complex than the production of traditional (